SCHEMBL6234510

SCHEMBL6234510

CC(C)(SSC(C)(C)[C@H](N)C(=O)O)C(N)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
MAPT P10636 1/20 0.54
PTGS1 P23219 1/20 0.54
TP53 P04637 1/20 0.36
KIF11 P52732 1/20 0.36
SLC7A5 Q01650 2/20 0.36
GRIK1 P39086 1/20 0.32
BHMT Q93088 3/20 0.32
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12438551 1.00 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1TP53KIF11
SCHEMBL2875767 1.00 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1TP53KIF11
SCHEMBL6555262 1.00 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1TP53KIF11
SCHEMBL6501684 1.00 ALDH1A1 (0.54) ALDH1A1MAPTPTGS1TP53KIF11
SCHEMBL19371196 0.88 ALDH1A1 (0.48) ALDH1A1MAPTPTGS1TP53KIF11
SCHEMBL7876560 0.82 ALDH1A1 (0.52) ALDH1A1MAPTPTGS1KIF11SLC7A5
SCHEMBL7418366 0.82 ALDH1A1 (0.52) ALDH1A1MAPTPTGS1KIF11SLC7A5
SCHEMBL7184921 0.82 ALDH1A1 (0.52) ALDH1A1MAPTPTGS1KIF11SLC7A5
SCHEMBL436388 0.80 PTGS1 (0.56) ALDH1A1MAPTPTGS1KIF11SLC7A5
SCHEMBL21443801 0.80 ALDH1A1 (0.50) ALDH1A1MAPTPTGS1KIF11SLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532976-A2 Compositions comprising organic disulfides, cysteine sulfoxides, sulfones, sulfoximines or other sulfur containing substances and their use in therapy in combination with radiation Holt, John Alfred Gorton (AU) 2005-05-25 EP disclosed
EP-0531031-B1 Compositions for use in cancer therapy HOLT JOHN ALFRED GORTON (AU) 1995-11-02 EP disclosed
EP-0531031-A1 Compositions for use in cancer therapy Holt, John Alfred Gorton (AU) 1993-03-10 EP disclosed